Vien Brewster

Vien Brewster is an experienced professional with a diverse background in finance and management. Starting in 2000, Vien worked at KPMG Canada as a Senior Accountant for five years before joining Nexans as an Accounting Manager. In 2006, Vien transitioned to YM BioSciences as a Controller, where they were responsible for various financial functions and played a key role in special projects. In 2013, Vien joined Impopharma Inc. as the Chief Financial Officer/Vice President of Finance, overseeing financial operations until 2018. From 2018 to 2019, Vien served as the Chief Operating Officer at Impopharma Canada Limited. Vien then moved on to become the General Manager at Rubicon Research Canada Limited from 2019 to 2022. Currently, Vien holds the position of Chief Financial Officer at KMH Cardiology Centres Inc. starting from 2022.

Vien Brewster completed a Masters of Accounting from the University of Waterloo in 2003. Prior to that, Vien also earned a BA in Honours Accountancy from the same university, completing it in 2002. Additionally, Vien obtained a certification as a Chartered Professional Accountant / Chartered Accountant from the Canadian Institute of Chartered Accountants in 2004.